Drug Profile
Research programme: CNS disorders therapeutics - Saniona/Janssen Pharmaceutica
Alternative Names: CNS disorder thearpeutics - NeuroSearch/Janssen Pharmaceutica; CNS disorders therapeutics - NsDiscovery/JanssenLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Aniona; Janssen Pharmaceutica
- Developer Saniona
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in CNS-disorders in Denmark
- 20 Mar 2014 Aniona is now called Saniona
- 20 Jan 2014 Early research is ongoing Denmark